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        DCs are well recognized for their role in the 
priming and diff  erentiation of naive T cells (  1, 2  ). 
Murine conventional DCs have been exten-
sively studied and have traditionally been di-
vided into fi  ve distinct subsets based on their 
expression of CD11b, CD4, CD8    , and Lan-
gerin. The spleen contains three of these sub-
sets (CD11b  +  CD4  +  , CD11b  +  CD4        CD8           , 
and CD11b        CD8      +  ), whereas LNs contain 
two additional populations (CD4        Langerin  +   
and CD4        CD8            CD11b  lo  ) that display a 
more mature phenotype and appear to repre-
sent tissue-derived migratory DCs (  3, 4  ). Al-
though the developmental relationships between 
these populations remains unclear, several of 
these subsets have been described to have dis-
tinct functional properties (  5, 6  ). Nevertheless, 
surprisingly few studies have attempted to char-
acterize DC subsets in human LN (  4, 7  –  10  ) and, 
thus, the possibility of targeting distinct con-
ventional DC subsets for regulating human im-
mune responses remains unclear. Indeed, to our 
knowledge functionally distinct conventional DC 
subsets in human LN have yet to be described. 
  Recent evidence suggests that the tissue 
environment in which DCs reside has a major 
impact on their phenotypic and functional 
properties. This is particularly apparent in the 
intestinal mucosa. Intestinal DCs are located 
throughout the villus lamina propria (LP) and 
in intestinal lymphoid tissue (Peyers Patches 
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  A functionally distinct subset of CD103  +   dendritic cells (DCs) has recently been identifi  ed 
in murine mesenteric lymph nodes (MLN) that induces enhanced FoxP3  +   T cell differentia-
tion, retinoic acid receptor signaling, and gut-homing receptor (CCR9 and     4    7) expres-
sion in responding T cells. We show that this function is specifi  c to small intestinal lamina 
propria (SI-LP) and MLN CD103  +   DCs. CD103  +   SI-LP DCs appeared to derive from circulat-
ing DC precursors that continually seed the SI-LP. BrdU pulse-chase experiments suggested 
that most CD103  +   DCs do not derive from a CD103        SI-LP DC intermediate. The majority 
of CD103  +   MLN DCs appear to represent a tissue-derived migratory population that plays a 
central role in presenting orally derived soluble antigen to CD8  +   and CD4  +   T cells. In con-
trast, most CD103        MLN DCs appear to derive from blood precursors, and these cells could 
proliferate within the MLN and present systemic soluble antigen. Critically, CD103  +   DCs 
with similar phenotype and functional properties were present in human MLN, and their 
selective ability to induce CCR9 was maintained by CD103  +   MLN DCs isolated from SB 
Crohn  ’  s patients. Thus, small intestinal CD103  +   DCs represent a potential novel target for 
regulating human intestinal infl  ammatory responses. 
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effi   ciently induced CCR9 on responding T cells, whereas 
CD103        SI-LP, CD103  +   and CD103        colonic LP, PP, and 
lung-draining LN DCs failed to do so (  Fig. 1, B and C  ). In 
contrast, all DC populations induced some     4    7 on respond-
ing OT-I cells (Fig. S2). CD103  +   DCs and, in particular, in-
testinal CD103  +   DCs induced higher levels of    4    7 compared 
with their CD103        counterparts. Although CD103        DCs 
induced less     4    7 expression, they were more effi   cient at 
inducing E-selectin ligand (which is required for eff  ector 
[PP], solitary isolated lymphoid tissue [SILT], and mesenteric 
LN [MLN]), where they play a central role in sampling and 
processing luminal as well as peripheral self antigen for pre-
sentation to T cells (  11  ). Several functional properties have 
recently been ascribed to murine intestinal DCs. These in-
clude an enhanced ability to promote FoxP3  +   regulatory 
T cell and IgA-secreting B cell diff  erentiation and induction 
of gut-homing receptors (CCR9 and     4    7) on responding T 
and B cells (  8, 12  –  17  ). Remarkably, these diverse functions 
appear, at least in part, to be driven through intestinal DC  –
  mediated retinoic acid receptors (RAR) signaling. Thus, the 
vitamin A metabolite retinoic acid (RA) induces expression of 
gut-homing receptors and enhances FoxP3  +   T cell and IgA B 
cell diff  erentiation, whereas RAR antagonists block the ability 
of intestinal DCs to generate these populations (  8, 18  –  20  ). 
  Only a subset of MLN DCs, which express the integrin      
chain CD103, are effi   cient at inducing gut-homing receptors 
on responding T cells and FoxP3  +   T cell diff  erentiation in 
vitro (  15  –  17  ). CD103  +   MLN DCs express higher levels of 
  aldh1a2  , the gene encoding RALDH2 (  15  ) which is a key 
enzyme involved in metabolizing retinal to RA, compared 
with their CD103        MLN counterparts. Consistent with this, 
CD103  +   MLN DCs induce enhanced RAR dependent 
signaling in responding T cells, compared with splenic or 
CD103        MLN DCs (  21  ). Despite these fi  ndings, the rela-
tionship between CD103  +   and CD103        MLN DC subsets 
and the functional properties of these subsets in other tissues, 
including the small intestinal and colonic LP, remains un-
known. Critically, it also remains to be determined whether 
these cells represent a functionally distinct population in hu-
man MLN and, thus, the potential of targeting CD103  +   DCs 
for regulating intestinal immunity in humans is unclear. 
    RESULTS   
  Murine small intestinal LP and MLN CD103  +   DCs are unique 
in their capacity to effi  ciently induce CCR9 and RAR 
signaling in responding T cells 
  CD103  +   DCs are present in a wide range of mucosal murine 
tissues and secondary lymphoid organs (  Fig. 1 A  ;   15, 17, 
22  –  25  ).   Although CD103  +   and CD103        DCs isolated from 
mucosal tissues (small intestine LP [SI-LP], colonic LP, and 
lung) were CCR7        CD40  lo  , the majority of CD103  +   DCs in 
LN (MLN, lung draining mediastinal LN, and peripheral [ax-
illary and brachial] LN) expressed CCR7 and high levels of 
CD40 and, thus, displayed a more mature phenotype than 
their peripheral counterparts and CD103        LN DCs (Fig. S1, 
A and B, available at http://www.jem.org/cgi/content/full/
jem.20080414/DC1; and not depicted). To determine whether 
the ability to effi   ciently induce CCR9 on T cells is a feature 
of all CD103  +   DCs, CFSE-labeled CD8  +  OT-I cells were 
primed with OVA peptide (pOVA; 2000 pM)  –  pulsed CD103  +   
and CD103        DCs from MLN, SI-LP, Colonic-LP, PP, and 
lung-draining LNs, and expression of tissue-homing recep-
tors on responding T cells was assessed 6 d later. As expected, 
CD103  +  , but not CD103       , MLN DCs induced CCR9 on 
responding OT-I cells (  Fig. 1 C  ). CD103  +   SI-LP DCs also 
    Figure 1.         Small intestinal LP and MLN CD103  +   DCs are unique in 
their capacity to effi  ciently induce CCR9 on responding T cells.  
(A) Percentage of DCs (MHC class II  + CD11c +  ) expressing CD103 in indicated 
organs. Results are the mean and SD from three to eight independent 
experiments (two to fi  ve mice per experiment). (B and C) CD103  +   and 
CD103        DCs were sorted from the indicated organs by FACS, pulsed with 
2 nM (B and C) or 200 pM (C) pOVA  257 – 264  , and incubated with OT-I cells. 
CCR9 expression on responding OT-I cells was assessed after 6 d by fl  ow 
cytometry. Representative FACS plots (B) and mean and SD (C) of the 
indicated number of separate experiments are shown. (D and E) CD103  +  
and CD103        DCs were sorted from the indicated organs by FACS, pulsed 
with 200 pM pOVA  257 – 264  , and incubated with DR5.OT-I cells. Luciferase 
activity was determined after 22 h of culture. Data are normalized to the 
luciferase expression observed in CD103  +   MLN DC:DR5.OT-I cell cultures 
within each experiment.     , DR5.OT-I cells alone. Results are the mean 
and SD of the indicated number of separate experiments. (E) Luciferase 
activity was blocked when 1   μ  M of the pan-RAR antagonist LE540 was 
added to MLN DC-T cell cultures. Results are the mean and SD of three 
experiments. *, P   <   0.05; **, P   <   0.01; ***, P   <   0.001 (compared with 
CD103  +   MLN DCs). LDLN, Lung draining LN; Co-LP, colonic LP.     JEM VOL. 205, September 1, 2008 
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CCR9 induction is not a general property of CD103  +   DCs 
or intestinal DCs but is selective for CD103  +   DCs that reside 
in the SI-LP and MLN. 
  CD103 is not required for intestinal DCs  ’   ability to generate 
gut tropic T cells 
  The results in the previous section clearly demonstrate that 
CD103 signaling is not suffi   cient to imprint DCs with the 
ability to effi   ciently induce CCR9 and enhanced RAR sig-
naling in responding T cells. However, it remained possible 
that CD103-mediated adhesion to E-cadherin on epithelial 
cells (  26  ) or putative ligands in the small intestinal LP (  27, 28  ) 
was required to expose CD103  +   DCs suffi   ciently to imprint-
ing signals. To assess this possibility, antigen-pulsed MLN 
DCs from CD103      /      and WT mice were assessed for their 
ability to induce CCR9 and     4    7 on responding DO11.10 
cells (  Fig. 2  ).   From these experiments, it is clear that 
CD103      /      MLN DCs are as effi   cient as WT MLN DCs at 
inducing CCR9. Thus, CD103 is simply a marker of DCs in 
the SI-LP and MLN that have an enhanced ability to induce 
RAR signaling in responding T cells. 
  CD103  +   SI-LP DCs derive from DC precursors that 
continually seed the intestinal LP 
  CD103 is induced on activated T cells subsequent to their 
entry into the intestinal mucosa (  29  –  31  ). Given the diff  eren-
tial ability of CD103  +   and CD103        SI-LP DCs to induce an 
RAR signal and CCR9 on responding T cells, we next de-
termined whether CD103  +   SI-LP DCs derive directly from a 
cell migration to extraintestinal sites of infl  ammation) on re-
sponding T cells than CD103  +   DCs, irrespective of their 
tissue origin (Fig. S2). We have recently demonstrated that 
OT-I cells express higher levels of CCR9 when primed with 
CD103  +   and CD103        MLN DCs that have been pulsed with 
a low-dose peptide (  21  ). Because CCR9 expression by OT-I 
cells, in addition to DCs, is also regulated by antigen dose, we 
next determined the ability of the diff  erent DC preparations 
to induce expression of CCR9 at a lower and more permis-
sive peptide dose. When we pulsed DCs with a 10-fold lower 
peptide dose (200 pM), CD103  +   PP and, to a lesser extent, 
CD103        PP DCs induced CCR9 on responding T cells, al-
though the percentage of cells expressing CCR9 remained 
signifi   cantly lower than that observed after priming with 
CD103  +   MLN DCs (  Fig. 1 C  ). CD103  +   colonic LP and 
lung-draining LN DCs also induced limited CCR9 expres-
sion under these conditions, whereas CD103        colonic LP, 
lung-draining LN, and splenic DC subsets failed to effi   ciently 
induce CCR9 (  Fig. 1 C   and not depicted). Thus, although 
the mechanism underlying the antigen dose-dependent regu-
lation of CCR9 expression by OT-I cells and whether CCR9 
expression is infl  uenced by antigen dose in other TCR trans-
genic systems are currently not known, these results demon-
strate that at a lower peptide dose, there is also an inherent 
diff  erence between CD103  +   and CD103        DCs, as well as 
between CD103  +   DCs derived from diff  erent tissues, in their 
ability to effi   ciently confer CCR9 expression to OT-I cells. 
  CD103  +   MLN DCs express greater   aldh1a2   levels com-
pared with CD103        MLN DCs (  15  ), and their effi   ciency in 
inducing CCR9 and, presumably, Foxp3  +   T reg cell diff  er-
entiation lies, at least in part, in an enhanced ability to induce 
RAR signaling in T cells (  21  ). To determine whether CCR9 
induction correlated with enhanced DC-mediated RAR sig-
naling, OT-I cells from OT-I.DR5 transgenic mice (which 
express luciferase under control of three RA response ele-
ment (DR5) repeats [reference   21  ]) were primed with pOVA 
(200 pM)-pulsed CD103  +   or CD103        DCs, and luciferase 
activity in responding cells was assessed after 22 h (  Fig. 1 D  ) 
at a time when OT-I cells have yet to divide (not depicted). 
We have previously demonstrated that DCs pulsed with 
2,000 or 200 pM pOVA induce similar levels of RAR signal-
ing in responding T cells (  21  ). CD103  +   MLN DCs induced 
signifi   cantly greater luciferase activity in OT-I.DR5 cells 
than their CD103  +   PP and colonic counterparts (  Fig. 1 D  ). 
In contrast, CD103  +   SI-LP DCs induced similar levels of 
RAR signaling as CD103  +   MLN DCs (  Fig. 1 D  ). DC-in-
duced luciferase activity was dependent on RAR signaling, 
as it was inhibited by addition of the pan-RAR antagonist 
LE540 to the cell cultures (  Fig. 1 E  ). Thus, the ability of 
CD103  +   MLN and SI-LP  +   DCs to effi   ciently induce CCR9 
correlates with an enhanced ability to induce RAR signaling 
in responding T cells. Although CD103  +   DCs in general ap-
peared to induce slightly enhanced luciferase activity com-
pared with CD103        DCs (consistent with their enhanced 
ability to induce     4    7), these results demonstrate that the 
ability to induce high levels of RAR signaling and effi   cient 
    Figure 2.         CD103 is not required for imprinting MLN DCs with the 
ability to induce CCR9 on responding T cells.   10 5   MLN DCs from WT 
and CD103     /     BALB/c mice were cultured together with 2   ×   10  5   CFSE-
labeled DO11.10   SCID   CD4 +   cells, and OVA and expression of CCR9 and 
   4   7 was assessed 6 (experiment 1 [Expt. 1]) or 7 (experiment 2) d later. 
(A) Representative FACS plots. (B) Mean and SD of three mice per group 
for both experiments.     2142 MURINE AND HUMAN SMALL INTESTINAL CD103  +   DC S     | Jaensson et al. 
were Ki67        and, thus, not actively dividing (  Fig. 3 B  ). Thus, 
there is a rapid turnover of both CD103  +   and CD103        DCs 
in the SI-LP. Further, because CD103  +   SI-LP DCs incorpo-
rated BrdU with at least as fast kinetics as CD103        DCs (even 
at 90 min after injection; not depicted), it appears that the 
majority of CD103  +   SI-LP DCs do not derive from a 
CD103        SI-LP DC intermediate but from an actively prolif-
erating DC precursor population. To examine whether the 
villus SI-LP DC compartment is replenished by blood-de-
rived or tissue-resident DC precursors, SI from C57BL/6.
CD45.2 mice was grafted into C57BL/6.CD45.1 mice (  32  ). 
The proportions of host- and graft-derived MHC class II-
  hi  CD11c  +   DCs were then determined in the small intestinal 
mucosa of the graft and host after 6 and 45 d by immunohis-
tochemistry (  Fig. 3 C  ). At both time points, almost all DCs 
in the small intestinal villi of the grafted intestine were of host 
origin and at similar levels to those found in the host  ’  s own 
SI (  Fig. 3 C  ). Together, these results suggest that the SI-villus 
DC compartment is not maintained by tissue resident precur-
sors but from DC precursors that continually seed the SI-LP 
from the circulation. 
  CD103  +   and CD103        SI-LP DCs are found primarily in villus 
LP and solitary isolated lymphoid tissue, respectively 
  Suspensions of LP cells generated by enzymatic digestion of 
intestine likely contain DCs from both villus and small-sized 
lymphoid follicles, which are also referred to as solitary intes-
tinal lymphoid tissue (SILT). Indeed, more than 1,000 SILT 
are interspersed throughout the small intestinal mucosa, and 
DCs constitute a major population in these structures. We 
therefore examined whether the CD103  +   and CD103        sub-
sets of DCs in our intestinal preparations could be diff  eren-
tially derived from these sites. Consistent with our previous 
results (  17  ), CD103  +   DCs (MHC class II  hi  CD11c  +   cells) were 
detected in the villus LP. In addition, CD103  +   DCs were 
observed in the subepithelial dome of SILT (  Fig. 4 A  ).   Quan-
titative analysis demonstrated that almost all MHC class II-
  hi  CD11c  +   cells in the villus expressed CD103, whereas the 
majority of MHC class II  hi  CD11c  +   cells in the dome re-
gion of SILT were CD103        (  Fig. 4 B  ). Of note, numerous 
CD11c  +   cells that failed to stain or stained very weakly with 
anti  –  MHC class II antibody (CD11c  +   MHC classsII  lo/      cells) 
were present within the villus LP (  Fig. 4 B  ), which is consis-
tent with previous results (  17  ); however, these cells did not 
express CD103 and their function and ontogeny remains to 
be determined. 
  The majority of CD103  +   and CD103        MLN DCs appear 
to represent tissue-derived migratory and lymphoid-resident 
populations, respectively 
  Because most CD103  +   SI-LP DCs appear not to derive from 
CD103        SI-LP DCs and because CD103  +   MLN DCs in-
duced greater RAR signaling in T cells compared with 
CD103        MLN DCs, we determined whether CD103  +   and 
CD103        were of similar origin in MLN. Mice received a 
single i.p. injection of BrdU, and the appearance of BrdU  +   
DC precursor or from CD103        SI-LP DCs (MHC class II  +   
CD11c  +   cells) that up-regulate CD103 in the SI-LP. Mice 
received a single injection of BrdU i.p., and the percentage of 
BrdU  +   CD103  +   and CD103        DCs in the SI-LP was deter-
mined over time (  Fig. 3 A  ).   3 h after BrdU injection, 8% (  ±   
5.1%) of CD103  +   SI-LP DCs were BrdU  +  , and this number 
increased to 16% (  ±   6.5%) by 9 h before leveling off  . In con-
trast, 7% (  ±   2.0%) of CD103        SI-LP DCs were BrdU  +   at 3 h, 
and this percentage increased only slightly over the subse-
quent 24-h period (  Fig. 3 A  ). BrdU  +   CD103  +   SI-LP DCs 
    Figure 3.         Turnover of SI-LP and MLN CD103  +   and CD103        DC.  
(A) Mice were injected i.p. with 2 mg BrdU, and the percentage of BrdU  +  
CD103  +   and CD103        DCs (MHC class II  + CD11c +  ) in the SI-LP and MLN was 
determined by fl  ow cytometry at the times indicated. Results are the 
mean and SD of three to seven independent experiments with two mice 
in each time point except the 72-h time point, which was performed 
once. (B) BrdU and Ki67 staining on SI-LP and MLN CD103  +   and  CD103      
DCs (MHC class II  +   CD11c +  ) was assessed by fl  ow cytometry 3 and 24 h 
after BrdU injection. Plots are from one representative experiment of 
three performed. (C) SI from CD45.2  +   mice (graft) was transplanted into 
CD45.1  +   recipients (host) as previously described (  32  ). At days 6 and 45, 
host and graft intestine were sectioned and stained with antibodies to 
CD45.2 (red), CD11c (blue), and MHC class II (green). Immunohistochemis-
try of the 45-d graft is shown. Arrows point to host-derived CD45.2      MHC 
class II  hi CD11c +   DCs. Bar, 25   μ  m. The graph is percentage of host-derived 
(CD45.2 negative) CD11c  +  MHC class II  hi   cells in graft and host small intes-
tinal villus. Results are mean and SD (  n   = 3 mice per group).     JEM VOL. 205, September 1, 2008 
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their distinct origins suggested that each subset might have 
distinct antigen-presenting function in vivo. To address this 
question, mice were immunized with OVA orally, killed 17 h 
later, and the ability of sorted CD103  +   and CD103        MLN 
DCs to prime OT-I or OT-II T cell was assessed in vitro. 
After oral OVA administration, only CD103  +   MLN DCs in-
duced OT-I and OT-II cell proliferation (  Fig. 5 A  ).   To deter-
mine whether this was caused by a general inability of CD103        
MLN DCs to process and present antigen to T cells, similar 
experiments were performed after i.p. OVA immunization. 
Under these conditions, both CD103  +   and CD103        MLN 
CD103  +   and CD103        DCs in the MLN was assessed over 
time. BrdU  +   CD103  +   DCs appeared in the MLN with much 
slower kinetics than in the SI-LP, with their numbers peak-
ing at 48 h (  Fig. 3 A  ). This is consistent with the idea that the 
majority of CD103  +   DCs in the MLN represent a tissue-de-
rived migratory population that enter the MLN via the aff  er-
ent lymph (  17, 33  ). In marked contrast, the bulk population 
of BrdU  +   CD103        DCs accumulated within the MLN with 
similar, if not more rapid, kinetics than in the SI-LP, with 
their numbers peaking 9 h after BrdU injection (  Fig. 3 A  ). 
Remarkably, most BrdU  +   CD103        MLN DCs were also 
Ki67  +   at 3 h and were thus actively proliferating (  Fig. 3 B  ). 
The percentage of CD103        MLN DCs that were Ki67  +   re-
mained constant (    6%) throughout the period of the experi-
ment, whereas the proportion of Ki67        BrdU  +   cells increased 
between 3 and 24 h as BrdU-labeled cells exited the cell cy-
cle. Together, these results demonstrate that the majority of 
CD103  +   and CD103        MLN DCs are of diff  erent origin. Al-
though most CD103  +   MLN DCs appear to represent a tis-
sue-derived migratory population, most CD103        MLN DCs 
appear to be maintained through continual and local homeo-
static proliferation and, potentially, through recruitment of 
blood-derived precursors. 
  CD103  +   MLN DCs play a key role in presenting orally 
administered soluble antigen to CD8  +   and CD4  +   T cells 
  Although antigen-pulsed CD103  +   and CD103        MLN DCs 
can both prime CD4  +   and CD8  +   T cells in vitro (  15, 17, 22  ), 
    Figure 4.         Localization of CD103  +   and CD103        MHC class II  +  CD11c  +   
cells within the small intestinal mucosa.   (A and B)     Expression of CD103 
by DCs in small intestinal villus and SILT. (A) Images show overlays of 
CD103 (red) in combination with CD11c (blue) and MHC class II (green), 
with insets showing DAPI staining. Arrows point toward MHC class II-
  hi CD11c +   DCs coexpressing CD103. Bars, 50   μ  m. (B) The graph is percentage 
of MHC class II  hi CD11c +   cells in SI villus or dome region of SILT that express 
CD103. Results are mean and SD (  n   = 5 mice per group). ***, P   <   0.001.     
    Figure 5.         CD103  +   DCs present orally administered soluble antigen 
to CD4  +   and CD8  +   T cells.   (A and B) Mice received PBS 5 mg OVA i.p., 
or 50 mg orally, and MLN were harvested after 17 h. 10  5   CD103 +   and 
CD103        MLN DCs were isolated by cell sorting and cocultured with 2   ×   10  5  
CFSE-labeled OT-I or OT-II cells. (A) CFSE profi  le of OT-I and OT-II cells 3.5 
d after coculture with indicated DCs. Data are representative of three to 
fi  ve separate experiments using MLN DCs isolated from 15  –  20 pooled 
mice per group. (B) Expression of CCR9 and    4   7 was analyzed by FACS 
after 3.5 d in coculture. The graph shows mean and SEM from fi  ve inde-
pendent experiments. *, P   <   0.05 (when comparing CD103  +   and  CD103      
DC – primed  cultures).   2144 MURINE AND HUMAN SMALL INTESTINAL CD103  +   DC S     | Jaensson et al. 
CD40 and CD83 (  Fig. 6, C and D  ).   CD103  +   DCs were also 
readily detected in MLN draining the infl  amed SI of Crohn  ’  s 
patients (  Fig. 6 B  ). To assess the functionality of CD103  +   and 
CD103        MLN DCs, these subsets were purifi  ed from pooled 
MLN draining normal SI (Fig. S3 B) and incubated together 
with allogeneic CFSE-labeled PBL. The expression of CCR9 
and     4    7 on responding CD8  +   T cells was assessed after 7 d 
(  Fig. 7, A  –  C  ).   As in the mouse, human CD103  +   MLN DCs 
induced signifi  cantly higher levels of CCR9 on responding 
CD8  +   T cells than their CD103        counterparts (  Fig. 7, A and B  ). 
In contrast, both DC populations induced similar expression 
of     4    7 (  Fig. 7, A and C  ). To determine whether the selec-
tive ability of CD103  +   MLN DCs to induce CCR9 was 
maintained in chronic small intestinal infl  ammatory disease, 
similar studies were performed with sorted MLN DCs from 
Crohn  ’  s patients. Because these LN were considerably en-
larged, pooling of LN was not required. As with DCs from 
normal MLN, only CD103  +   DCs effi   ciently induced CCR9 
on responding T cells (  Fig. 7 B  ), whereas both populations 
effi   ciently induced     4    7 (  Fig. 7 C  ). Finally, induction of 
CCR9 and     4    7 by human CD103  +   MLN DCs was depen-
dent on RAR signaling as gut-homing receptor expression 
was inhibited by addition of LE540 to the cultures (  Fig. 7 D  ). 
Together, these results demonstrate a remarkable cross-spe-
cies preservation of the phenotypic and functional properties 
of CD103  +   MLN and demonstrate that these functional 
properties are maintained in Crohn  ’  s disease. 
    DISCUSSION   
  Recent studies have highlighted an important role for intesti-
nal DCs (  12, 14, 18  ) and, in particular, intestinal CD103  +   
DC (  8, 15  –  17, 21  ) in inducing RAR signaling and gut-hom-
ing receptor expression on responding T cells and FoxP3  +   
Treg diff  erentiation. In this paper, we show that SI-LP and 
MLN CD103  +   DCs induce greater RAR signals and more 
effi   ciently induce CCR9 in responding T cells than other 
CD103  +   or CD103        DC populations. We provide evidence 
DCs were capable of inducing OT-I and OT-II proliferation 
(  Fig. 5 A  ). Notably, CD103        DCs consistently induced more 
OT-II cell proliferation than CD103  +   DCs (  Fig. 5 A   and not 
depicted). Thus, although both DC populations are capable 
of presenting and cross-presenting antigen to CD8  +   and 
CD4  +   T cells, CD103  +   MLN DCs are of primary importance 
in driving T cell responses to orally administered soluble an-
tigen. Because the majority of CD103  +   MLN DCs appear to 
represent an LP-derived migratory population and OT-I cells 
are not primed in the MLN of CCR7      /      mice after oral 
OVA administration (  17  ), these results further suggest that 
CD103  +   DC migration from the LP is required to drive 
T cell responses to luminal soluble antigen in the MLN. 
  Finally, because both DC subsets isolated from i.p.-im-
munized mice induced some OT-I cell proliferation, we 
compared induction of gut-homing receptors on responding 
cells (  Fig. 5 B  ). OT-I cells primed with CD103  +   DCs ex-
pressed signifi  cantly higher levels of CCR9 and high levels of 
    4    7 compared with OT-I cells primed with CD103        DCs 
(  Fig. 5 B  ). The limited induction of CCR9 on CD103        DC-
primed OT-I cells likely refl  ects the level of peptide being 
presented by these cells, because CD103        MLN DCs pulsed 
with low peptide dose are capable of inducing some CCR9 
on responding OT-I cells (  21  ). 
  CD103  +   DCs are present in human MLN and effi  ciently 
induce CCR9 on responding T cells 
  Finally, to determine whether studies of murine CD103  +   
MLN DCs were translatable to the human, we determined 
whether CD103  +   DCs are present in human MLN. CD103  +   
DCs were readily detected in MLN draining the normal SI, 
although the percentage of CD103  +   DCs showed consider-
able variation (  Fig. 6, A and B  ; for gating strategy see Fig. 
S3 A, available at http://www.jem.org/cgi/content/full/jem
.20080414/DC1). As in the mouse (  17  ), human CD103  +   
MLN DCs displayed a more mature phenotype compared 
with their CD103        counterparts, as judged by expression of 
    Figure 6.         Phenotypic characterization of human CD103  +   and CD103        MLN DCs.   (A) Human MLN section stained with anti  –  DC-LAMP (FITC), 
CD103 (Cy3), and IgG (Cy5) antibody to identify B cell follicles for orientation in the LN. CD103  +   DCs (yellow). Bar, 100   μ  m. (B) Percent of DCs expressing 
CD103 in normal and Crohn  ’  s MLN, as determined by fl  ow cytometry using the DC gatings described in Fig. S2 A (available at http://www.jem.org/cgi/
content/full/jem.20080414/DC1). Filled squares, normal MLN (bladder reconstruction patients;   n   = 9); open squares, colon cancer patients (  n   = 4); tri-
angles, SB Crohn  ’  s patients (  n   = 6). (C and D) CD40 and CD83 expression on CD103  +   and  CD103       normal MLN DCs using the gatings described in Fig. S2 A 
(available at http://www.jem.org/cgi/content/full/jem.20080414/DC1). Representative FACS plots (C) and mean and SD (D) of three (CD83) or four (CD40) 
independent experiments. **, P   <   0.01. Results are normalized within each experiment to the percent expression on CD103  +   DCs.   JEM VOL. 205, September 1, 2008 
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and, notably, not of CD103  +   Co-LP DCs but of SI-LP and 
MLN CD103  +   DCs. As the latter population appears to de-
rive from the former (see subsequent Discussion paragraphs), 
these results argue for a selective imprinting of CD103  +   DCs, 
or their immediate precursors, in the SI-LP. In this regard, vi-
tamin A itself is primarily absorbed through the SI (  34  ), and 
incubation of monocyte-derived DCs with RA imprinted on 
these cells the ability to induce CCR9 on responding T cells 
(  35  ). This activity was blocked with a RAR antagonist, but 
not a RALDH inhibitor, leading to the suggestion that CCR9 
induction may be mediated by RA that has been taken up and 
stored by DCs. Nevertheless, incubation with high concen-
tration of RA (1,000 nM) was required for this eff  ect, and the 
in vivo relevance of these fi  ndings remains unclear. CD103  +   
SI-LP and MLN DCs express higher levels of   aldh1a2   (un-
published data) (15) than their CD103        counterparts, suggest-
ing that their enhanced ability to induce RAR signaling may 
lie in an increased capacity to metabolize retinal. Although 
the signals inducing   aldh1a2   expression and the link between 
  aldh1a2   expression and DC-mediated RAR signaling remains 
unclear, addition of IL-4 to MLN DC-T cell cultures was re-
cently found to enhance CCR9, but not     4    7, expression on 
responding CD4  +   T cells (  36  ). Notably, MLN DCs from IL-
4r          /      mice displayed a reduced capacity to induce CCR9 
on CD4  +   T cells and had reduced levels of   aldh1a2   (  36  ), al-
though the composition of MLN DCs in these mice was not 
assessed. Moreover, CD8  +   T cells in the SI-LP of IL-4r          /      
expressed normal levels of CCR9. In the current study, the 
inability of CD103        SI-LP DCs to induce enhanced RAR 
signaling suggests that imprinting signals are not ubiquitously 
expressed in the SI-LP or that CD103        SI-LP DCs are inca-
pable of responding to such signals. Notably, although CD103 
expression on DCs appears to play a critical functional role 
in T cell  –  mediated regulation of CD45RB  hi   T cell  –  induced 
colitis (  22  ), our experiments with CD103      /      MLN DCs 
demonstrate that CD103 is not required for imprinting intes-
tinal DCs with the ability to generate gut tropic T cells. 
  Irrespective of the imprinting mechanism, the similar ini-
tial kinetics of BrdU  +   cells within the CD103  +   and CD103        
LP DC populations suggest that CD103  +   SI-LP DCs are not 
the progeny of CD103        SI-LP (MHC class II  +  CD11c  +  ) 
DCs. Moreover, our intestinal transplant experiments suggest 
that CD103  +   SI-LP DCs do not derive from resident prolif-
erating precursors within the LP but are continually replen-
ished by blood-borne precursors seeding the LP. This result, 
however, should be interpreted with a degree of caution, as 
we cannot at this point rule out that infl  ammation associated 
with the transplant surgery triggers the release of donor-de-
rived DC precursors that are replaced by precursors of host 
origin. In the rat, small numbers of DCs were found in intes-
tinal lymph that originated from adoptively transferred blood 
monocytes (  37  ), indicating that at least some intestinal-LP 
migratory DCs are monocyte derived. Consistent with this 
possibility, murine CD11b  +  Gr1  +   monocytes generate CD11c  +   
LP cells when transferred into LP-DC  –  depleted recipient 
mice (  38  ), although further phenotypic analysis of the resulting 
that most CD103  +   SI-LP DCs develop directly from a circu-
lating DC precursor, and not from CD103        SI-LP DCs, and 
that the majority of CD103  +   MLN DCs represent a SI-LP  –
  derived migratory population that plays a critical role in pre-
senting orally derived soluble antigen to T cells. Thus, these 
cells presumably capture orally applied antigens locally in the 
SI and subsequently migrate into the MLN. In contrast, most 
CD103        MLN DCs appear to represent a blood-derived LN 
population that can proliferate in the MLN and present sys-
temic antigen to T cells. Critically, we also demonstrate that 
CD103  +   DCs are present in normal and infl  amed human 
MLN and display similar phenotypic and functional prop-
erties to their murine counterparts. Thus, CD103  +   MLN 
DCs represent a potential novel target population for regulat-
ing human intestinal immune responses. 
  Our current results demonstrate that although all DCs ap-
pear to be capable of inducing limited RAR signaling in 
T cells, the ability to induce high RAR signaling and effi   cient 
CCR9 expression is not a general property of CD103  +   DCs 
    Figure 7.         Human MLN CD103  +   DCs effi  ciently induce CCR9 on 
responding T cells.   (A – C)  CCR9  and    4   7 expression on CD8  +   T  cells 
primed with CD103  +   or  CD103       DCs from normal (A  –  C) or SB Crohn  ’  s 
(B and C) MLN. DCs were sorted as described in Materials and methods and 
Fig. S2 B (available at http://www.jem.org/cgi/content/full/jem.20080414/DC1). 
(A) Representative fl  ow cytometry plots. (B) CCR9 expression on T cells 
stimulated with CD103  +   (empty symbols) or CD103        MLN DCs (fi  lled sym-
bols). Each symbol represents a separate experiment and horizontal line 
represents the mean value. Boxes in A show the gates that were used to 
assess CCR9 expression. (C)    4   7 expression on T cells stimulated with 
CD103  +   or CD103        MLN DCs. Normal, mean and SD of four experiments; 
Crohn  ’  s, mean of two experiments. Because    4   7 is induced in a cell 
cycle  –  dependent manner (  12, 13, 54  ),    4   7 expression was assessed on 
cells that had divided six to nine times (arrows in A). (D) Gut-homing re-
ceptor induction by CD103  +   DCs from normal human MLN was inhibited 
by addition of 1   μ  M of the pan-RAR antagonist LE540 to the cell cultures. 
Results are mean and SD of four separate experiments. ***, P   <   0.001.     2146 MURINE AND HUMAN SMALL INTESTINAL CD103  +   DC S     | Jaensson et al. 
i.p. OVA (  17, 51  ), provides further evidence that CD103  +   
MLN DCs represent the major tissue-derived migratory DC 
population that presents soluble luminal antigen to T cells. 
  We have previously demonstrated that CCR9 is more ef-
fi  ciently induced on adoptively transferred OT-I cells in the 
MLN after oral compared with i.p. OVA administration (  12  ). 
Thus, effi   cient induction of CCR9 correlates with enhanced 
antigen presentation by CD103  +   DCs. Further, OT-I cells 
primed in the MLN of CCR7      /      mice after administration 
of OVA and adjuvant i.p. fail to express CCR9 (  12  ). Thus, 
reduced levels of CD103  +   DCs in the MLN correlate with 
reduced CCR9 induction. Together, these correlations 
strongly indicate that CD103  +   MLN DCs are required for 
effi   cient CCR9 induction in vivo. Although     4    7 induction 
is also greatest under conditions of highest CCR9 induction, 
    4    7 is also induced on OT-I cells after i.p. OVA adminis-
tration alone in both WT and CCR7      /      mice. Because in-
duction of     4    7 is RAR dependent (  21  ), these results suggest 
that RAR signaling provided by additional cells in the 
MLN is suffi   cient to induce some     4    7 expression on T cells 
primed at this site. Indeed,     4    7 is induced on proliferating 
antigen-specifi  c T cells in the MLN after i.p. injection of an-
tigen-loaded BM or peripheral LN DCs (  52  –  54  ). Determin-
ing the precise role of CD103  +   MLN DC  –  mediated RAR 
signaling in the generation of gut tropic T cells and FoxP3  +   
T reg cell diff  erentiation will likely require analysis of im-
mune responses in mice selectively depleted of this unique 
subset of DCs. 
  To our knowledge, the phenotype and function of dis-
tinct DC subsets in human intestinal LN has not previously 
been examined. Given the unique functional characteristics 
of murine CD103  +   MLN DCs and their potentially impor-
tant role in regulating intestinal immune responses, it was of 
central importance to determine the relevance of this popula-
tion in humans. CD103  +   DCs were readily detected in MLN, 
draining both healthy SI and the SI of patients with Crohns 
disease. These cells, as in the mouse, displayed a more mature 
phenotype than their CD103        counterparts. Total human 
MLN, but not splenic or liver, DCs have previously been 
shown to effi   ciently induce gut-homing receptors on re-
sponding B cells through an RAR-dependent mechanism 
(  8  ). Importantly, we demonstrate that the ability to induce 
CCR9 is not a general property of human MLN DCs but, 
again, selective for CD103  +   MLN DCs. Moreover, the selec-
tive ability of CD103  +   MLN DCs to induce CCR9 was 
maintained in Crohn  ’  s disease patients. Together, these re-
sults highlight the relevance of studying this population in 
murine models of intestinal homeostasis and infl  ammation and 
the future possibility of targeting these cells to regulate hu-
man intestinal immune responses in health and disease. 
    MATERIALS AND METHODS   
  Mice and human tissues 
  C57BL/6 (Taconic), DR5 (provided by R. Blomhoff  , Institute of Basic 
Medical Science, University of Oslo, Norway), OT-I, OT-II, and DR5.
OT-I mice (  21  ) were bred and maintained at the Biomedical Center animal 
facility (Lund University, Lund, Sweden). BALB/c, CD103      /      BALB/c, 
population was not performed. It also remains to be deter-
mined whether CD103  +   or CD103        SI-LP DCs derive from 
distinct DC precursors in the steady state or whether the same 
DC precursor population can generate both subsets depend-
ing on the microenvironmental signals they receive. The for-
mer possibility is supported by the recent observation that 
CCR2  +  Ly6C  hi   and CX3CR1  +  Ly6C  lo   monocyte subsets re-
plenish CD103  +   and CD103        lung DCs, respectively (  39  ). 
  Our current results also provide strong evidence that the 
majority of CD103  +   and CD103        MLN DCs derive from 
distinct populations of DCs. The delayed appearance of 
BrdU  +   CD103  +   DCs in MLN compared with the SI-LP is 
compatible with the idea that most of these cells represent a 
tissue-derived migratory population. Consistent with this 
hypothesis, CD103  +   DC numbers are reduced in the MLN of 
mice lacking CCR7, a chemokine receptor which is required 
for DC migration from peripheral tissues into the draining 
LN (  17, 24, 40, 41  ). CD103  +   Langerin  +   DCs are present 
in the lung (  23  ) and are reduced in numbers in the LDLN 
of CCR7      /      mice (  24, 25  ). Furthermore, a radiosensitive 
CD103  +   Langerin  +   DC population was recently identifi  ed in 
the skin dermis (  42  –  44  ) that migrates to the skin, draining 
LN in the steady state in a CCR7-dependent manner (  42  –
  44  ). Together, these results suggest that most CD103  +   DCs 
in intestinal and extraintestinal LN represent tissue-derived 
migratory DCs. 
  In marked contrast to CD103  +   DCs, BrdU  +   CD103        
DCs accumulated with at least as rapid kinetics in the MLN 
as in the SI-LP, suggesting that the majority of these cells in 
MLN represent a resident population. In addition, most 
CD103        LN DCs displayed an immature phenotype under 
steady state, a proposed characteristic of LN-resident DCs 
(  45, 46  ). Several mechanisms have been reported to help 
maintain the splenic and LN-resident DC compartment in 
the steady state. These include continuous recruitment of DC 
precursors from the blood and diff  erentiation from tissue res-
ident DC precursors, as well as a limited expansion of DCs 
themselves (  47  –  50  ). We found that     6% of CD103  -   DCs in 
the MLN were Ki67  +   at any one time and were thus actively 
proliferating. Further, in combined Ki67 and BrdU staining, 
    60% of BrdU  +   CD103        DCs were Ki67  +   3 h after BrdU 
administration, suggesting that in the steady state, the CD103        
DC population is maintained in part through homeostatic 
proliferation and in part through the entry of DC precursors 
from the blood. 
  Our observations that only CD103  +   MLN DCs induce 
OT-I and OT-II proliferation after oral OVA administration 
demonstrate a key role for these cells in cross-presenting 
orally derived soluble antigen and confi  rm the importance of 
these cells in presenting oral antigen to CD4  +   T cells (  15  ). 
We further show that this is not caused by a defect in the 
ability of CD103        MLN DCs to present antigen, as these 
cells primed OT-I and, especially, OT-II cells after i.p. ad-
ministration of antigen. These results, together with previous 
observations that OT-I and OT-II cells fail to respond to 
orally administered OVA in CCR7      /      mice but respond to JEM VOL. 205, September 1, 2008 
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nal DCs (  17, 21  ). CFSE labeling of T cells and fl  ow cytometry analysis was 
performed as previously described (  55  ). Data acquisition was performed on a 
FACSCalibur or FACSAria (BD Biosciences) and analyzed using FlowJo 
software (Tree Star, Inc.). 
  Human cell isolation and fl  ow cytometry analysis 
  Lymphocytes were isolated from peripheral blood using LymphoLyte-H 
(Cedarlane Laboratories.). Human MLN DCs were isolated using one of two 
protocols: (a) MLN were cut into small pieces and incubated in R10 with 
500   μ  g/ml collagenase IV and 50 U/ml DNase I for 10 min at 37  °  C on an 
orbital shaker (Innova 2300; New Brunswick Scientifi  c) at 250 rpm. Re-
maining tissue was mechanically crushed and, together with the cell suspen-
sion, passed through a 70-  μ  m cell strainer. Cells were stained and either 
analyzed or sorted using a FACSAria. (b) MLN pieces were mechanically 
disaggregated in HBSS supplemented with 5% FCS and 5 mM EDTA (Sigma-
Aldrich) at 230 rpm for 5 min in a circulator (Stomacher 400; Seward). The 
resulting sample was passed through a fi  ne mesh and washed with HBSS. Su-
pernatant was mixed with OptiPrep (AxisShield) 1:3 and overlayered with 
11.5% OptiPrep and HBSS. Samples were centrifuged at 600   g   for 20 min 
and the DC fraction was harvested. Remaining lymphocytes were depleted 
with anti-CD3 dynabeads (Invitrogen) and DCs isolated by CD11c ex-
pression using EasySep (StemCell Technologies Inc.). CD11c  +   HLA-DR  +   
cells were FACS sorted into CD103  +   and CD103        DC fractions. Both pro-
tocols yielded similar proportions of CD103  +   and CD103        MLN DCs. Data 
acquisition was performed using FACSAria or Cyan fl  ow cytometer (Dako) 
and data analyzed using FlowJo or Summit software (Dako). 
  In vitro and ex vivo cell cultures 
  Murine cell cultures.     DCs were pulsed with 2 nM or 200 pM SIIN-
FEKL peptide for 1 h at 37  °  C, washed extensively, and incubated (10  5   
cells) with 2   ×   10  5   CFSE-labeled OT-I cells in fl  at bottom 96-well plates 
(Thermo Fisher Scientifi  c) in 200   μ  l of complete R10 medium. The 
phenotype of responding OT-I cells was assessed by fl  ow cytometry after 
3.5 d or after expansion for an additional 2 d as previously described (  21  ). 
For luciferase measurements, DR-5.OT-I cells and antigen-pulsed DCs 
were cocultured and luciferase activity was assessed after 22 h as previ-
ously described (  21  ). For ex vivo DC cultures, CD103  +   and CD103        
MLN DCs were FACS sorted from OVA-immunized mice and cultured 
(10  5   cells) together with 2   ×   10  5   CFSE-labeled OT-I cells for 3.5 d be-
fore analysis. 
  Human cell cultures.     CFSE-labeled PBL were cultured together with 5   ×   
10  5   allogeneic CD103        or CD103  +   MLN DCs at a 1:1 ratio in R10 medium 
supplemented with 400 IU/ml IL-2 (Proleukin). Proliferation and 
CCR9/    4    7 expression on CD8  +   T cells were measured after 7 d by fl  ow 
cytometry. 
  Small bowel transplantation 
  The small bowel transplantation was performed as previously described (  32  ). 
  Immunohistochemistry 
  Staining of mouse tissue.     Staining was performed as previously described 
(  17  ) using CD11c-APC (N418), CD103-PE (M290), MHC class II  –  biotin 
(2G9), DAPI, and streptavidin  –  Alexa 488. 
  Staining of human tissue.     Acetone-fi  xed MLN sections were blocked with 
10% NGS (Sigma-Aldrich) and avidin-biotin blocking kit (Vector Labora-
tories). Tissue was stained with anti  –  DC-LAMP (104.G4; Beckman Coulter) 
followed by FITC-labeled goat anti  –  mouse antibody (Jackson ImmunoRe-
search Laboratories). After washing and blocking with 10% NMS, sections 
were stained with biotin anti-CD103 (28C12) and visualized using a tyramide 
signal amplifi  cation kit (PerkinElmer Life Science) and Cy3-conjugated strep-
tavidin (Biosite). Sections were costained with Cy5-labeled donkey anti  –
  human IgG F(ab  ’  )2 (Jackson ImmunoResearch Laboratories). Images were 
acquired with a microscope (Axiovert 200M; Carl Zeiss, Inc.) and Volocity 
software (Improvision) or AxioVision 4.0 software (Carl Zeiss, Inc.). 
and DO11.10 mice were bred and maintained in animal Facilities at the 
University of Oxford (Oxford, England, UK). Mice between 6 and 14 wk 
of age were used for experiments. Animal experiments were performed in 
accordance with guidelines from Lund/Malm  ö   Animal Ethics Committee, 
the review board of the Hannover Medical School, or the UK Animals (Sci-
entifi  c Procedures) Act of 1986 where appropriate. 
  Normal MLN were obtained from patients undergoing bladder recon-
struction by cystectomy (  n   = 9) or surgery for colon cancer (  n   = 4). Infl  amed 
MLN were obtained from patients with SB Crohn  ’  s disease (  n   = 6). All tis-
sues were obtained with informed patient consent and in accordance with 
local ethical approval from the Regional Ethics committee in Lund (Sweden) 
and the South Birmingham Research Ethics committee (England, UK). 
  Reagents 
  R10 medium contained the following reagents, all from Invitrogen: RPMI-
1640, 10% FCS, 10 mM Hepes, 1 mM sodium pyruvate, 50   μ  M mercapto-
ethanol, 100 U/ml penicillin, 100   μ  g/ml streptomycin, and 50   μ  g/ml 
gentamicin. HBSS was obtained from Invitrogen. Synthetic pOVAs (OT-I, 
SIINFEKL; and OT-II, ISQAVHAAHAEINEAGR) were obtained from 
Innovagen. OVA grade VII, LPS (  Escherichia coli  , serotype 055:B55), DNase I, 
and collagenase type IV and VIII were obtained from Sigma-Aldrich. OVA 
was purifi  ed using Detoxi-Gel Endotoxin removal gel (Thermo Fisher 
Scientifi  c). CFSE (Sigma-Aldrich) and LE540 (Wako Chemicals USA, Inc.) 
were dissolved in DMSO. 
  Cell staining reagents 
  The following reagents were used to stain murine cells:     unconjugated or di-
rectly conjugated anti-CD103 (M290), anti-    4    7 (DATK32), anti-CD62L 
(MEL-14), anti-MHC class II (2G9), anti-CD11c (N418), and rat IgG2a and 
IgG2b isotype controls (BD Biosciences); perCP-Cy5.5, Alexa 700  –  conju-
gated anti-CD11c (N418), and Pacifi  c blue  –  conjugated anti  –  MHC Class II 
(M5/114.15.2; BioLegend); anti-CCR7 (4B12; eBiosciences); recombinant 
mouse E-selectin human Fc chimera (R &  D Systems); anti-FcRII/III (2.4G2), 
anti-CD40 (FGK45), anti-CD86 (GL1), and anti-CCR9 antibody (7E7, (56); 
purifi  ed from hybridomas); Cy5-labeled donkey anti  –  human IgG F(ab  ’  )2 
(Jackson ImmunoResearch Laboratories); biotinylated mouse anti  –  rat IgG2a 
(RG7/1.30), biotinylated mouse anti  –  rat IgG2b (G15-337), PE-labeled 
Ki67, streptavidin-conjugated PE, PECy7, PerCP Cy5.5, and the BrdU 
FITC fl  ow kit (BD Biosciences); streptavidin  –  alexa 488 (Invitrogen); and 
DAPI (Sigma-Aldrich). 
  The following reagents were used to stain human DCs:     APC-conju-
gated anti-CD40 (5C3), APC-Cy7  –  conjugated anti  –  HLA-DR (L243), PE-
Cy5  –  conjugated anti-    7 (FIB504), and APC-Cy7  –  conjugated anti-CD8 
(SK7; BD Biosciences); PE-Cy7  –  conjugated anti-CD11c (3.9), biotinylated 
or PE-Cy5  –  conjugated anti-CD83 (HB15e), PE-conjugated anti-CD103 
(BLy7), APC/PE/PE-Cy5  –   or biotin-conjugated IgG  1   isotype controls, and 
FITC-conjugated anti-CD3 (UCHT1), -CD14 (61D3), -CD16 (CB16), 
-CD19 (HIB19), and -CD56 (MEM188; eBiosciences); PE-Cy7  –  conjugated 
anti-CD3 (UCHT1; Beckman Coulter); APC-conjugated anti-CCR9 (R  &  D 
Systems); PE-conjugated anti-CD8 (DK2) and FITC/PE-conjugated anti-
CD103 (Ber  –  ACT8; Dako); FITC/Cy7-conjugated anti-CD11c (BU15) 
and FITC/Cy5-conjugated anti  –  HLA-DR (YE2/36HLK; AbD Serotec); 
and mouse anti  –  human     4    7 (ACT-1; provided by M. Briskin, Millennium 
Pharmaceuticals, Inc.). 
  Murine cell isolation and fl  ow cytometry analysis 
  Murine T cells and DCs were purifi  ed by MACS as previously described (  17  ). 
T cell purity was 90  –  95%. DCs were     95% CD11c  +   and 90% CD11c  +  MHC 
class II  +  . For CD103  +   and CD103        DC purifi  cation, MACS-enriched 
CD11c  +   DCs were sorted using anti-CD11c, anti-CD103, and anti  –  MHC 
class II on a FACSAria (BD Biosciences;   17  ). DC fractions were routinely 
95  –  99% pure. In   Fig. 1 (B  –  E)  , DCs were isolated from mice injected with 
FMS-like tyrosine kinase-3 ligand (Flt3L)-secreting B16 melanoma cells, as 
previously described (  17  ). Such treatment does not infl  uence the selective 
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